Professional Documents
Culture Documents
Emkay - Shriram City Union Finance - Errclub - Refer To Important Disclosures at The End of This Report Weak Asset Quality Weighs On Earnings
Emkay - Shriram City Union Finance - Errclub - Refer To Important Disclosures at The End of This Report Weak Asset Quality Weighs On Earnings
Emkay - Shriram City Union Finance - Errclub - Refer To Important Disclosures at The End of This Report Weak Asset Quality Weighs On Earnings
earnings Rating
HOLD ()
Upside
(3.8) %
Change in Estimates
Shriram City Union Finance (SCUF) delivered stable operating performance, however
EPS Chg FY18E/FY19E (%) (13)/(12)
steep increase in credit costs led by transitioning to 120-dpd NPL recognition and higher
write offs weighed heavily on the bottomline Target Price change (%) (5.4)
Target Period (Months) 12
Reported GNPLs increased to 6.7% (on 120-days outstanding basis) from 4.5% (on 150-
Previous Reco HOLD
days outstanding basis) in Q3FY17; Credit costs stood at 7.2% (annualized) as the
Emkay vs Consensus
company wrote off Rs1.4bn worth loans and maintained PCR at ~73%
EPS Estimates
Disbursements grew 21% qoq (+20% yoy) at Rs62.5bn on the back of pickup in the FY18E FY19E
enterprise financing business; Meanwhile the two-wheeler financing business witnessed
Emkay 100.7 133.2
slower growth due to lagged impact of demonetization and regulatory hurdles
Consensus 98.3 119.0
We prune our FY18/19E estimates by an average ~13% to factor in slower growth and Mean Consensus TP (12M) Rs 2,317
higher credit costs for core as well as housing finance business. We maintain our HOLD Stock Details
rating with a revised SOTP-based target price of Rs2,100
Bloomberg Code SCUF IN
Face Value (Rs) 10
Asset quality deteriorates on regulatory transitioning: Gross NPLs increased to 6.7% Shares outstanding (mn) 66
from 4.5% in Q3FY17, as SCUF migrated its NPL recognition to 120-dpd basis. The
52 Week H/L 2,650 / 1,504
Q3FY17 asset quality performance was buoyed by the RBI dispensation for deferment of
M Cap (Rs bn/USD bn) 144 / 2.24
NPL recognition (Rs2bn worth loans fell under dispensation). The company managed to
Daily Avg Volume (nos.) 55,960
recover c.60% of such loans and the rest has been classified as NPLs in Q4FY17. Credit
Daily Avg Turnover (US$ mn) 1.8
costs rose to 7.2% (annualized) as the company wrote off loans worth Rs1.4bn and
maintained provision coverage ratio (PCR) at 73%. As indicated by the management, Shareholding Pattern Mar '17
GNPLs at 90-dpd NPL recognition basis stood 9.7% higher than 9.5% in Q3FY17. Going
Promoters 33.8%
forward, the management has guided for bringing down the provision coverage ratio to
FIIs 21.9%
60% as they migrate to 90-dpd NPL recognition next fiscal.
DIIs 6.0%
Demand in SME revives; two-wheeler remains subdued: AUMs grew 18%% yoy / 3% Public and Others 38.4%
qoq to Rs231bn. Notably, the non-gold segments continue to drive growth as the portfolio
grew 22% yoy (+3% qoq). Disbursements grew strongly post demonetization by 21% qoq Price Performance
(+20% yoy) to Rs62.5bn led by strong demand in the SME business. The demand in the (%) 1M 3M 6M 12M
two-wheeler business was affected due to the lagged impact of demonetization and the Absolute (8) 15 (14) 31
regulatory changes in the auto space. The management has guided for 20%+ AUM growth Rel. to Nifty (8) 8 (19) 12
in FY18.
Relative price chart
Margins contract ~140bps qoq: SCUFs calculated net interest margins contracted 2600 Rs % 50
~140bps qoq to 12.5% mainly due to Rs560m interest income reversal. Going forward too, 2380 38
the management has guided for some pressure on NIMs as they migrate to 90-dpd NPL 2160 26
Shriram Housing Finance (SHF) performance: SHF AUMs contracted 4% qoq (+38% 1720 2
yoy) to Rs17.6bn. During the quarter the company sold Rs500m worth NPLs to ARC. As a
1500 -10
result, reported GNPLs fell to 2.6% from 3.7% in Q3FY17. Management has guided for May-16 Jul-16 Sep-16 Nov-16 Jan-17 Mar-17 May-17
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
Shriram City Union Finance (SCUF IN) India Equity Research | Result Update
Total AUM (Rs bn) 231,320 225,430 195,750 18.2% 2.6% 231,320 195,750 18.2%
Gross NPA 15,370 9,930 9,800 56.8% 54.8% 15,370 9,800 56.8%
Net NPA 4,100 1,250 2,970 38.0% 228.0% 4,100 2,970 38.0%
Gross NPA (% of loans) 6.7% 4.5% 5.2% 6.7% 5.2%
Net NPA (% of loans) 1.8% 0.6% 1.6% 1.8% 1.6%
Provision coverage ratio (%) 73.3% 87.4% 69.7% 73.3% 69.7%
Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
May 3, 2017 2
Shriram City Union Finance (SCUF IN) India Equity Research | Result Update
Exhibit 5: AUM growth remain healthy Exhibit 6: AUM mix remains largely unchanged
4Q'15
4Q'16
4Q'17
1Q'14
2Q'14
3Q'14
1Q'15
2Q'15
3Q'15
1Q'16
2Q'16
3Q'16
1Q'17
2Q'17
3Q'17
0%
FY13 FY14 FY15 FY16 FY17
AUM (Rs bn) Growth (% yoy; RHS) Small Enterprises Two wheeler Loan against gold Others
Source: Company, Emkay Research Source: Company, Emkay Research
Exhibit 7: SME business drives growth Exhibit 8: Net interest margins falls sharply on regulatory migration
60% 15.0%
40% 14.5%
14.0%
20% 13.5%
0% 13.0%
-20% 12.5%
12.0%
-40% 11.5%
-60% 11.0%
10.5%
1Q'15
2Q'15
3Q'15
4Q'15
1Q'16
2Q'16
3Q'16
4Q'16
1Q'17
2Q'17
3Q'17
4Q'17
10.0%
3Q'14
1Q'13
2Q'13
3Q'13
4Q'13
1Q'14
2Q'14
4Q'14
1Q'15
2Q'15
3Q'15
4Q'15
1Q'16
2Q'16
3Q'16
4Q'16
1Q'17
2Q'17
3Q'17
4Q'17
Small Enterprises Two wheeler Loan against gold
Source: Company, Emkay Research Source: Company, Emkay Research
Exhibit 9: Asset quality worsens Exhibit 10: Credit costs remain elevated
1Q'16
2Q'16
3Q'16
4Q'16
1Q'17
2Q'17
3Q'17
4Q'17
2.0%
2Q'15
1Q'13
2Q'13
3Q'13
4Q'13
1Q'14
2Q'14
3Q'14
4Q'14
1Q'15
3Q'15
4Q'15
1Q'16
2Q'16
3Q'16
4Q'16
1Q'17
2Q'17
3Q'17
4Q'17
GNPA (%) NNPA (%) PCR (%)
Source: Company, Emkay Research Source: Company, Emkay Research
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
May 3, 2017 3
Shriram City Union Finance (SCUF IN) India Equity Research | Result Update
Balance Sheet
Y/E Year End (Rs mn) FY15 FY16 FY17 FY18E FY19E
Equity 659 659 659 659 659
Reserves 40,352 44,457 48,823 53,924 61,163
Net worth 41,011 45,116 49,483 54,583 61,822
Deposits 0 0 0 0 0
Borrowings 124,021 144,084 170,420 206,724 255,548
Total liabilities 180,380 208,544 245,365 292,695 353,555
Cash and bank 7,814 6,419 6,371 5,121 2,893
Investments 9,817 7,923 7,145 10,336 12,777
Loans 158,903 191,406 229,614 274,824 335,274
Others 3,024 1,947 1,453 1,554 1,665
Total assets 180,380 208,544 245,365 292,695 353,555
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
May 3, 2017 4
Shriram City Union Finance (SCUF IN) India Equity Research | Result Update
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES.
May 3, 2017 5
Shriram City Union Finance (SCUF IN) India Equity Research | Result Update
DISCLAIMERS AND DISCLOSURES: Emkay Global Financial Services Limited (CIN-L67120MH1995PLC084899) and its affiliates are a full-service, brokerage, investment banking, investment
management and financing group. Emkay Global Financial Services Limited (EGFSL) along with its affiliates are participants in virtually all securities trading markets in India. EGFSL was established in 1995
and is one of India's leading brokerage and distribution house.EGFSL is a corporate trading member of Bombay Stock Exchange Limited (BSE), National Stock Exchange of India Limited(NSE), MCX Stock
Exchange Limited (MCX-SX).EGFSL along with its subsidiaries offers the most comprehensive avenues for investments and is engaged in the businesses including stock broking (Institutional and retail),
merchant banking, commodity broking, depository participant, portfolio management, insurance broking and services rendered in connection with distribution of primary market issues and financial products
like mutual funds, fixed deposits. Details of associates are available on our website i.e. www.emkayglobal.com
EGFSL is registered as Research Analyst with SEBI bearing registration Number INH000000354 as per SEBI (Research Analysts) Regulations, 2014. EGFSL hereby declares that it has not defaulted with
any stock exchange nor its activities were suspended by any stock exchange with whom it is registered in last five years, except that NSE had disabled EGFSL from trading on October 05, October 08 and
October 09, 2012 for a manifest error resulting into a bonafide erroneous trade on October 05, 2012. However, SEBI and Stock Exchanges have conducted the routine inspection and based on their
observations have issued advice letters or levied minor penalty on EGFSL for certain operational deviations in ordinary/routine course of business. EGFSL has not been debarred from doing business by
any Stock Exchange / SEBI or any other authorities; nor has its certificate of registration been cancelled by SEBI at any point of time.
EGFSL offers research services to clients as well as prospects. The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject
company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report.
Other disclosures by Emkay Global Financial Services Limited (Research Entity) and its Research Analyst under SEBI (Research Analyst) Regulations, 2014 with reference to the subject
company(s) covered in this report-:
EGFSL or its associates may have financial interest in the subject company.
Research Analyst or his/her relatives financial interest in the subject company. (NO)
EGFSL or its associates and Research Analyst or his/her relatives does not have any material conflict of interest in the subject company. The research Analyst or research entity (EGFSL) have not been
engaged in market making activity for the subject company.
EGFSL or its associates may have actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of Research Report.
Research Analyst or his/her relatives have actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of Research
Report: (NO)
EGFSL or its associates may have received any compensation including for investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EGFSL or its
associates may have received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. EGFSL or
its associates may have received any compensation or other benefits from the Subject Company or third party in connection with the research report. Subject Company may have been client of EGFSL or
its associates during twelve months preceding the date of distribution of the research report and EGFSL may have co-managed public offering of securities for the subject company in the past twelve months.
The research Analyst has served as officer, director or employee of the subject company: (NO)
The Research Analyst has received any compensation from the subject company in the past twelve months: (NO)
The Research Analyst has managed or comanaged public offering of securities for the subject company in the past twelve months: (NO)
The Research Analyst has received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months: (NO)
The Research Analyst has received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months:
(NO)
The Research Analyst has received any compensation or other benefits from the subject company or third party in connection with the research report: (NO)
EGFSL and/or its affiliates may seek investment banking or other business from the company or companies that are the subject of this material. Our salespeople, traders, and other professionals may provide
oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make
investment decisions that may be inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all of the foregoing, among other things, may give
rise to real or potential conflicts of interest including but not limited to those stated herein. Additionally, other important information regarding our relationships with the company or companies that are the
subject of this material is provided herein. This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or
other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would subject EGFSL or its group companies to any registration or licensing requirement
within such jurisdiction. Specifically, this document does not constitute an offer to or solicitation to any U.S. person for the purchase or sale of any financial instrument or as an official confirmation of any
transaction to any U.S. person. Unless otherwise stated, this message should not be construed as official confirmation of any transaction. No part of this document may be distributed in Canada or used by
private customers in United Kingdom. All material presented in this report, unless specifically indicated otherwise, is under copyright to Emkay. None of the material, nor its content, nor any copy of it, may
be altered in any way, transmitted to, copied or distributed to any other party, without the prior express written permission of EGFSL . All trademarks, service marks and logos used in this report are trademarks
or registered trademarks of EGFSL or its Group Companies. The information contained herein is not intended for publication or distribution or circulation in any manner whatsoever and any unauthorized
reading, dissemination, distribution or copying of this communication is prohibited unless otherwise expressly authorized. Pl ease ensure that you have read Risk Disclosure Document for Capital Market
and Derivatives Segments as prescribed by Securities and Exchange Board of India before investing in Indian Securities Market. In so far as this report includes current or historic information, it is believed
to be reliable, although its accuracy and completeness cannot be guaranteed.
Emkay Research is also available on www.emkayglobal.com, Bloomberg EMKAY<GO>, Reuters and DOWJONES. www.emkayglobal.com
May 3, 2017 6